Claudia Walz
Dr. iur. HSG
Attorney-at-Law
Location:
Phone:
+41 58 258 10 00
Languages:
German
English
VCard:
Download
Vita
Claudia Walz advises on cross-border as well as national real estate and corporate transactions, private equity, M&A. She also advises in commercial administrative law proceedings, including Lex Koller, antitrust, foundation and trademark matters.
Admitted to the Swiss Bar since 2018.
Professional career
- Attorney at Law, Bratschi Ltd. (since 2023)
- Attorney at Law, Lenz & Staehelin, Zurich (2022)
- Attorney at Law, Baker McKenzie, Zurich (2021)
- Law Clerk, Federal Administrative Court, St.Gallen (2018)
- Auditor, Federal Administrative Court, St.Gallen (2016)
- Associate, Gleiss Lutz, Stuttgart (2014)
- Substitute, Baker McKenzie, Zurich (2012)
Education
- Dr. iur. HSG, University of St.Gallen (2024)
- M.A. HSG in Law and Economics, University of St.Gallen (2014)
Other activities
- Lecturer on competition law at the Swiss School of International Business (SSIB), Zurich (2022)
Memberships
- Swiss Bar Assoociation
- Zurich Bar Association
- Altsalemer Association
- DocNet - Doctoral Network at the University of St.Gallen
- Data Science & Technology Club at the University of St.Gallen
- HSG Alumni
- ASAS / LIDC
More from Claudia Walz
Know-how
bratschiLETTER
Externe Untersuchungen: Was dürfen Revisionsgesellschaften und Kanzleien?
Die Bundesverwaltung sieht sich regelmässig mit der Frage konfrontiert, ob externe Revisionsgesellschaften oder Kanzleien mit…
Learn more
bratschiBLOG
öff-recht blog: EU-Entwaldungsverordnung: Einjährige Verlängerung der Umsetzungsfristen und zusätzliche Leitlinien der EU-Kommission
Die EU-Entwaldungsverordnung (EUDR) bringt tiefgreifende Veränderungen für den Handel mit der EU. Als Teil des EU Green Deals…
Learn more
News
06.11.2025
Bratschi represents the University Hospital Basel in the takeover of the Claraspital Basel in merger control proceedings before COMCO
The University Hospital Basel will take over the Claraspital Basel and the other companies of the Clara Group. Thereby, one of…
Learn more
13.05.2025
Bratschi Advises Shareholders on the Sale of Cerbios-Pharma to HAS
HAS Healthcare Advanced Synthesis SA has acquired Chemholding due SA and its subsidiaries. The main operating company is…
Learn more